Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
2.031
-0.129 (-5.96%)
At close: Jun 26, 2026, 4:00 PM EDT
2.000
-0.031 (-1.54%)
After-hours: Jun 26, 2026, 6:37 PM EDT
Pluri Employees
As of June 30, 2025, Pluri had 142 total employees, including 127 full-time and 15 part-time employees. The number of employees increased by 24 or 20.34% compared to the previous year.
Employees
142
Change (1Y)
24
Growth (1Y)
20.34%
Revenue / Employee
$7,599
Profits / Employee
-$179,852
Market Cap
21.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evaxion | 46 |
| Vistagen Therapeutics | 41 |
| Longeveron | 38 |
| Quantum BioPharma | 17 |
| BriaCell Therapeutics | 16 |
| Tvardi Therapeutics | 12 |
| VYNE Therapeutics | 10 |
| Neuphoria Therapeutics | 8 |
PLUR News
- 11 days ago - Plurilock Announces Results of Annual General Meeting - Newsfile Corp
- 25 days ago - Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing - GlobeNewsWire
- 3 months ago - Pluri announces additional $2.5M investment from Alejandro Weinstein - TheFly
- 4 months ago - Pluri secures global IP position with CNIPA for immune cell expansion - TheFly
- 5 months ago - Pluri completes first phase of program with Resbiomed Technologies OOD - TheFly
- 6 months ago - Pluri announces expansion of manufacturing agreement with Remedy Cell - TheFly
- 6 months ago - Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved - GlobeNewsWire
- 7 months ago - Pluri appoints Weinstein as Chairman of the Board of Directors - TheFly